Connection

Allen Kaplan to Kininogen, High-Molecular-Weight

This is a "connection" page, showing publications Allen Kaplan has written about Kininogen, High-Molecular-Weight.
  1. Cytokine and estrogen stimulation of endothelial cells augments activation of the prekallikrein-high molecular weight kininogen complex: Implications for hereditary angioedema. J Allergy Clin Immunol. 2017 Jul; 140(1):170-176.
    View in: PubMed
    Score: 0.534
  2. Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II. J Allergy Clin Immunol. 2013 Aug; 132(2):470-5.
    View in: PubMed
    Score: 0.419
  3. Factor XII-independent cleavage of high-molecular-weight kininogen by prekallikrein and inhibition by C1 inhibitor. J Allergy Clin Immunol. 2009 Jul; 124(1):143-9.
    View in: PubMed
    Score: 0.315
  4. Interaction of high molecular weight kininogen binding proteins on endothelial cells. Thromb Haemost. 2004 Jan; 91(1):61-70.
    View in: PubMed
    Score: 0.219
  5. High molecular weight kininogen and factor XII binding to endothelial cells and astrocytes. Thromb Haemost. 2003 Nov; 90(5):787-95.
    View in: PubMed
    Score: 0.217
  6. Assessment of the role of heparan sulfate in high molecular weight kininogen binding to human umbilical vein endothelial cells. J Thromb Haemost. 2003 Nov; 1(11):2444-9.
    View in: PubMed
    Score: 0.217
  7. Inhibition of contact activation by a kininogen peptide (HKH20) derived from domain 5. Int Immunopharmacol. 2002 Dec; 2(13-14):1875-85.
    View in: PubMed
    Score: 0.203
  8. Activation of the plasma kinin forming cascade along cell surfaces. Int Arch Allergy Immunol. 2001 Jan-Mar; 124(1-3):339-42.
    View in: PubMed
    Score: 0.178
  9. Cytokeratin 1 and gC1qR mediate high molecular weight kininogen binding to endothelial cells. Clin Immunol. 1999 Sep; 92(3):246-55.
    View in: PubMed
    Score: 0.162
  10. Interaction of factor XII and high molecular weight kininogen with cytokeratin 1 and gC1qR of vascular endothelial cells and with aggregated Abeta protein of Alzheimer's disease. Immunopharmacology. 1999 Sep; 43(2-3):203-10.
    View in: PubMed
    Score: 0.162
  11. Platelet glycoprotein Ib: a zinc-dependent binding protein for the heavy chain of high-molecular-weight kininogen. Mol Med. 1999 Aug; 5(8):555-63.
    View in: PubMed
    Score: 0.161
  12. Complement, Kinins, and Hereditary Angioedema: Mechanisms of Plasma Instability when C1 Inhibitor is Absent. Clin Rev Allergy Immunol. 2016 Oct; 51(2):207-15.
    View in: PubMed
    Score: 0.133
  13. The bradykinin-forming cascade: a historical perspective. Chem Immunol Allergy. 2014; 100:205-13.
    View in: PubMed
    Score: 0.113
  14. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway. Adv Immunol. 2014; 121:41-89.
    View in: PubMed
    Score: 0.110
  15. The plasma bradykinin-forming pathways and its interrelationships with complement. Mol Immunol. 2010 Aug; 47(13):2161-9.
    View in: PubMed
    Score: 0.086
  16. The bradykinin-forming cascade and its role in hereditary angioedema. Ann Allergy Asthma Immunol. 2010 Mar; 104(3):193-204.
    View in: PubMed
    Score: 0.084
  17. Assembly, activation, and signaling by kinin-forming proteins on human vascular smooth muscle cells. Am J Physiol Heart Circ Physiol. 2005 Jul; 289(1):H251-7.
    View in: PubMed
    Score: 0.061
  18. Activation of the bradykinin-forming cascade on endothelial cells: a role for heat shock protein 90. Int Immunopharmacol. 2002 Dec; 2(13-14):1851-9.
    View in: PubMed
    Score: 0.051
  19. Protease activity in single-chain prekallikrein. Blood. 2020 02 20; 135(8):558-567.
    View in: PubMed
    Score: 0.042
  20. Nomenclature of factor XI and the contact system. J Thromb Haemost. 2019 12; 17(12):2216-2219.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.